文献速递头颈部肿瘤放疗姑息放疗与转移瘤

接受放射治疗的头颈部癌症长期幸存者的慢性疲劳

Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy.
PubMed 文献 · Radiother Oncol · 2024-03-20

这项横断面研究纳入2007-2013年接受放疗的227例头颈部癌症幸存者,中位随访8.5年,比较其慢性疲劳与匹配参考人群的差异。结果显示幸存者慢性疲劳患病率为参考人群的两倍,女性、合并症和调强放疗与慢性疲劳相关,而放疗剂量参数无关联;有慢性疲劳者健康相关生活质量显著更差。

要点

  • 头颈部癌症幸存者慢性疲劳患病率为匹配参考人群的两倍。
  • 女性(OR 3.39)、合并症(OR 2.17)和调强放疗(OR 2.13)与慢性疲劳相关。
  • 有慢性疲劳的幸存者健康相关生活质量显著更差。

核心结论

  • 头颈部癌症幸存者的慢性疲劳在女性患者中尤为重要,而特定的放疗相关因素似乎不起作用。
  • 长期头颈部癌症幸存者中高慢性疲劳患病率与健康相关生活质量受损相关,这是有益于临床医生和患者改善随访的重要信息。

研究设计与样本

  • 横断面研究,纳入2007-2013年接受放疗的头颈部癌症幸存者227例,中位年龄65岁,中位随访时间8.5年。
  • 参与者填写患者报告结局测量工具并接受一日检查,慢性疲劳采用疲劳问卷测量,与匹配参考人群比较采用t检验和Cohen效应量。
  • 慢性疲劳与临床及放疗相关因素的关联采用逻辑回归分析,健康相关生活质量采用EORTC生活质量核心问卷测量。

主要发现

  • 头颈部癌症幸存者慢性疲劳患病率为参考人群的两倍。
  • 多变量分析中,女性(OR 3.39,95%CI 1.82-6.31)、合并症(OR 2.17,95%CI 1.20-3.94)和调强放疗(OR 2.13,95%CI 1.16-3.91)与慢性疲劳相关,而放疗剂量参数无关联。
  • 有慢性疲劳的幸存者与无慢性疲劳者相比,健康相关生活质量显著更差。

关键数值与推荐

  • 女性与慢性疲劳的OR为3.39(95%CI 1.82-6.31)。
  • 合并症与慢性疲劳的OR为2.17(95%CI 1.20-3.94)。
  • 调强放疗与慢性疲劳的OR为2.13(95%CI 1.16-3.91)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is lack of evidence on chronic fatigue (CF) following radiotherapy (RT) in survivors of head and neck cancer (HNC). We aimed to compare CF in HNC survivors > 5 years post-RT with a reference population and investigate factors associated with CF and the possible impact of CF on health-related quality of life (HRQoL). MATERIAL AND METHODS: In this cross-sectional study we included HNC survivors treated in 2007-2013. Participants filled in patient-reported outcome measures and attended a one-day examination. CF was measured with the Fatigue Questionnaire and compared with a matched reference population using t-tests and Cohen's effect size. Associations between CF, clinical and RT-related factors were investigated using logistic regression. HRQoL was measured with the EORTC Quality of Life core questionnaire. RESULTS: The median age of the 227 HNC survivors was 65 years and median time to follow-up was 8.5 years post-RT. CF was twice more prevalent in HNC survivors compared to a reference population. In multivariable analyses, female sex (OR 3.39, 95 % CI 1.82-6.31), comorbidity (OR 2.17, 95 % CI 1.20-3.94) and treatment with intensity-modulated RT (OR 2.13, 95 % CI 1.16-3.91) were associated with CF, while RT dose parameters were not. Survivors with CF compared to those without, had significantly worse HRQoL. CONCLUSIONS: CF in HNC survivors is particularly important for female patients, while specific factors associated with RT appear not to play a role. The high CF prevalence in long-term HNC survivors associated with impaired HRQoL is important information beneficial for clinicians and patients to improve patient follow-up.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Huynh TM, Falk RS, Hellebust TP, et al. Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy. Radiother Oncol. 2024. PMID: 38518958. doi:10.1016/j.radonc.2024.110231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。